• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性卒中的脑微出血的潜在栓塞和病理差异。

Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke.

机构信息

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Department of Neurology, Tokyo Medical University Hospital, Tokyo, Japan.

出版信息

J Neurol. 2020 May;267(5):1482-1490. doi: 10.1007/s00415-020-09732-4. Epub 2020 Feb 3.

DOI:10.1007/s00415-020-09732-4
PMID:32016623
Abstract

BACKGROUND

Cryptogenic stroke encompasses diverse emboligenic mechanisms and pathogeneses. Cerebral microbleeds (CMBs) occur differently among stroke subtypes. The association of CMBs with cryptogenic stroke is essentially unknown.

METHODS

CHALLENGE ESUS/CS (Mechanisms of Embolic Stroke Clarified by Transesophageal Echocardiography for ESUS/CS) is a multicenter registry with comprehensive data including gradient-echo T2*-weighted magnetic resonance imaging of cryptogenic stroke patients who underwent transesophageal echocardiography. Patients' clinical characteristics were compared according to the presence and location of CMBs.

RESULTS

A total of 661 patients (68.7 ± 12.7 years; 445 males) were enrolled, and 209 (32%) had CMBs. Age (odds ratio [OR] 1.02, 95% confidence interval [CI] 1.00-1.04, p = 0.020), male sex (OR 1.85, 95% CI 1.18-2.91, p = 0.007), hypertension (OR 1.71, 95% CI 1.03-2.86, p = 0.039), chronic kidney disease (OR 1.64, 95% CI 1.11-2.43, p = 0.013), deep and subcortical white matter hyperintensity (OR 1.82, 95% CI 1.16-2.85, p = 0.009), and periventricular hyperintensity (OR 2.18, 95% CI 1.37-3.46, p = 0.001) were independently associated with the presence of CMBs. Aortic complicated lesions (OR 1.78, 95% CI 1.12-2.84, p = 0.015) were associated with deep and diffuse CMBs, whereas prior anticoagulant therapy (OR 7.88, 95% CI, 1.83-33.9, p = 0.006) was related to lobar CMBs.

CONCLUSIONS

CMBs were common, and age, male sex, hypertension, chronic kidney disease, and cerebral white matter diseases were related to CMBs in cryptogenic stroke. Aortic complicated lesions were associated with deep and diffuse CMBs, while prior anticoagulant therapy was related to lobar CMBs.

摘要

背景

隐源性卒中包括多种栓子形成机制和发病机制。脑微出血(CMBs)在不同类型的卒中中发生情况不同。CMBs 与隐源性卒中的关系尚不清楚。

方法

CHALLENGE ESUS/CS(经食管超声心动图明确 ESUS/CS 的栓塞性卒中机制)是一项多中心登记研究,包含接受经食管超声心动图检查的隐源性卒中患者的全面数据,包括梯度回波 T2*-加权磁共振成像。根据 CMBs 的存在和位置比较患者的临床特征。

结果

共纳入 661 例患者(68.7±12.7 岁;445 例男性),其中 209 例(32%)有 CMBs。年龄(比值比 [OR] 1.02,95%置信区间 [CI] 1.00-1.04,p=0.020)、男性(OR 1.85,95%CI 1.18-2.91,p=0.007)、高血压(OR 1.71,95%CI 1.03-2.86,p=0.039)、慢性肾脏病(OR 1.64,95%CI 1.11-2.43,p=0.013)、深部和皮质下脑白质高信号(OR 1.82,95%CI 1.16-2.85,p=0.009)和脑室周围高信号(OR 2.18,95%CI 1.37-3.46,p=0.001)与 CMBs 的存在独立相关。主动脉复杂病变(OR 1.78,95%CI 1.12-2.84,p=0.015)与深部弥漫性 CMBs 相关,而既往抗凝治疗(OR 7.88,95%CI 1.83-33.9,p=0.006)与脑叶 CMBs 相关。

结论

CMBs 很常见,年龄、男性、高血压、慢性肾脏病和脑白质疾病与隐源性卒中的 CMBs 有关。主动脉复杂病变与深部弥漫性 CMBs 相关,而既往抗凝治疗与脑叶 CMBs 相关。

相似文献

1
Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke.隐匿性卒中的脑微出血的潜在栓塞和病理差异。
J Neurol. 2020 May;267(5):1482-1490. doi: 10.1007/s00415-020-09732-4. Epub 2020 Feb 3.
2
Deep cerebral microbleeds are associated with the severity of lacunar infarcts and hypertension: A retrospective analysis.深部脑微出血与腔隙性脑梗死的严重程度及高血压相关:一项回顾性分析。
Medicine (Baltimore). 2018 Jun;97(23):e11031. doi: 10.1097/MD.0000000000011031.
3
Cerebral Microbleeds and Chronic Kidney Disease in Acute Ischemic Stroke Patients with Atrial Fibrillation.脑微出血与伴有心房颤动的急性缺血性脑卒中患者的慢性肾脏病。
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104650. doi: 10.1016/j.jstrokecerebrovasdis.2020.104650. Epub 2020 Feb 3.
4
Cerebral microbleeds in patients with acute subarachnoid hemorrhage.急性蛛网膜下腔出血患者的脑微出血。
Neurosurgery. 2014 Feb;74(2):176-81; discussion 181. doi: 10.1227/NEU.0000000000000244.
5
The prevalence and risk factors of cerebral microbleeds in patients with Parkinson's disease.帕金森病患者脑微出血的患病率及危险因素
Parkinsonism Relat Disord. 2015 Sep;21(9):1076-81. doi: 10.1016/j.parkreldis.2015.06.019. Epub 2015 Jun 26.
6
Large aortic arch plaques correlate with CHADS and CHADS-VASc scores in cryptogenic stroke.大动脉弓斑块与隐匿性卒中的 CHADS 和 CHADS-VASc 评分相关。
Atherosclerosis. 2019 May;284:181-186. doi: 10.1016/j.atherosclerosis.2019.03.009. Epub 2019 Mar 20.
7
Deep cerebral microbleeds are negatively associated with HDL-C in elderly first-time ischemic stroke patients.老年首发缺血性脑卒中患者深部脑微出血与高密度脂蛋白胆固醇呈负相关。
J Neurol Sci. 2013 Feb 15;325(1-2):137-41. doi: 10.1016/j.jns.2012.12.022. Epub 2013 Jan 11.
8
Atrial Septal Aneurysm may Cause In-Hospital Recurrence of Cryptogenic Stroke.房间隔动脉瘤可导致隐源性卒中住院期间复发。
J Atheroscler Thromb. 2021 May 1;28(5):514-523. doi: 10.5551/jat.56440. Epub 2020 Jul 17.
9
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.微出血与不明来源栓塞性卒中患者抗凝治疗的效果:NAVIGATE ESUS 随机临床试验的探索性分析。
JAMA Neurol. 2021 Jan 1;78(1):11-20. doi: 10.1001/jamaneurol.2020.3836.
10
Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status.癌症状态与不明原因卒中患者动脉粥样硬化栓子来源患病率的差异。
J Am Heart Assoc. 2021 Nov 2;10(21):e021375. doi: 10.1161/JAHA.120.021375. Epub 2021 Oct 23.

引用本文的文献

1
Atherogenic Dyslipidemia Is Critically Related to Aortic Complicated Lesions in Cryptogenic Stroke.致动脉粥样硬化性血脂异常与隐源性卒中的主动脉复杂病变密切相关。
J Atheroscler Thromb. 2025 Jul 1;32(7):804-822. doi: 10.5551/jat.65289. Epub 2024 Dec 26.
2
Overview and Future Direction of Embolic Stroke of Undetermined Source from the Insights of CHALLENGE ESUS/CS Registry.不明来源栓塞性卒中的概述和未来方向:来自 CHALLENGE ESUS/CS 登记研究的见解。
J Atheroscler Thromb. 2024 Dec 1;31(12):1641-1651. doi: 10.5551/jat.RV22026. Epub 2024 Sep 27.
3
Atrial cardiopathy is associated with cerebral microbleeds in ischemic stroke patients.

本文引用的文献

1
Prevalence and Risk Factors of Cerebral Microbleeds in Patients with Nonvalvular Atrial Fibrillation: An Enhanced T2*-Weighted Angiography Imaging Study.非瓣膜性心房颤动患者脑微出血的患病率及相关危险因素:一项增强 T2*-加权血管成像研究。
Eur Neurol. 2019;81(3-4):112-119. doi: 10.1159/000501123. Epub 2019 Jun 11.
2
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.脑微出血与缺血性卒中和短暂性脑缺血发作后卒中风险:来自队列研究的个体患者数据的汇总分析。
Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23.
3
心房心肌病与缺血性中风患者的脑微出血有关。
Front Neurol. 2022 Sep 1;13:982926. doi: 10.3389/fneur.2022.982926. eCollection 2022.
4
Evaluating the Potential Pathology and Short-Term Outcomes of Cryptogenic Stroke Using the Etiological Classification System.运用病因分类系统评估隐源性卒中的潜在病理和短期预后。
J Atheroscler Thromb. 2023 Apr 1;30(4):377-389. doi: 10.5551/jat.63267. Epub 2022 Jun 12.
5
Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status.癌症状态与不明原因卒中患者动脉粥样硬化栓子来源患病率的差异。
J Am Heart Assoc. 2021 Nov 2;10(21):e021375. doi: 10.1161/JAHA.120.021375. Epub 2021 Oct 23.
6
Different aspects of early and late development of atrial fibrillation during hospitalization in cryptogenic stroke.隐匿性卒中住院期间心房颤动的早期和晚期发展的不同方面。
Sci Rep. 2021 Mar 29;11(1):7127. doi: 10.1038/s41598-021-86620-5.
7
Dynamic Cerebral Autoregulation in Embolic Stroke of Undetermined Source.不明来源栓塞性卒中的动态脑自动调节
Front Physiol. 2020 Oct 20;11:557408. doi: 10.3389/fphys.2020.557408. eCollection 2020.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
达比加群酯预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
4
Large aortic arch plaques correlate with CHADS and CHADS-VASc scores in cryptogenic stroke.大动脉弓斑块与隐匿性卒中的 CHADS 和 CHADS-VASc 评分相关。
Atherosclerosis. 2019 May;284:181-186. doi: 10.1016/j.atherosclerosis.2019.03.009. Epub 2019 Mar 20.
5
Stroke Outcomes in the COMPASS Trial.COMPASS 试验中的卒中结局。
Circulation. 2019 Feb 26;139(9):1134-1145. doi: 10.1161/CIRCULATIONAHA.118.035864.
6
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.急性缺血性卒中和短暂性脑缺血发作(TIA)后接受抗凝治疗的房颤患者的脑微出血和颅内出血风险(CROMIS-2):一项多中心观察性队列研究。
Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.
7
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.利伐沙班预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.
8
Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).脑微出血的神经影像学关联:社区动脉粥样硬化风险研究(ARIC研究)
Stroke. 2017 Nov;48(11):2964-2972. doi: 10.1161/STROKEAHA.117.018336. Epub 2017 Oct 10.
9
Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.不明来源栓塞性卒中:系统评价与临床进展
Stroke. 2017 Apr;48(4):867-872. doi: 10.1161/STROKEAHA.116.016414. Epub 2017 Mar 6.
10
Difference in the Location and Risk Factors of Cerebral Microbleeds According to Ischemic Stroke Subtypes.根据缺血性卒中亚型分析脑微出血的位置及危险因素差异
J Stroke. 2016 Sep;18(3):297-303. doi: 10.5853/jos.2016.00360. Epub 2016 Sep 30.